Non-alcoholic fatty liver. Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: B: moderate intensity exercise therapy. Intervention 2: Intervention group: C: high intensity exercise therapy. Intervention 3: Control group: A: lifestyle modifica
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients with non-alcoholic fatty liver proved by clinical and laboratory examinations and imaging of their disease. All patients with fatty liver, which, despite the normal ultrasound examination, have only increased liver enzymes, it is not a drug and viral and genetic diseases, and fibroscan has a high capscore score (an estimated percentage of fat in the liver). Having another liver disease or any chronic disease that affects the function or histology of the liver All patients have to undergo initial examinations Not having a history of regular exercise before starting treatment.
Exclusion criteria
Exclusion criteria: Patients who have started using other therapies during the study are excluded from the study. Patients who refrain from continuing treatment during the study Patients who refuse diagnostic tests during the study The occurrence of any new condition or disorder that may interfere with the outcome of the patient's assessments Taking alcohol or drugs that affect the liver
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Maximum exercise capacity. Timepoint: Before starting treatment and 6 months later. Method of measurement: cardiopulmonary exercise test. | — |
Primary
| Measure | Time frame |
|---|---|
| Fibrosis score by fibroscan. Timepoint: Before starting treatment and 6 months after starting treatment. Method of measurement: fibroscan. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactdr Mohammad Hassabi
Shahid Beheshti University of Medical Sciences
Outcome results
None listed